Clinical Risk Grouping Solution Global Market Report 2025
상품코드:1810850
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
임상 리스크 그룹화 솔루션 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 연평균 성장률(CAGR) 12.4%로 11억 달러 규모로 성장할 것입니다. 예측 기간의 성장은 맞춤형 의료 관리로의 전환, 정부 의료 프로그램 확대, 예측 분석에 대한 수요 증가, 집단건강관리에 대한 집중 강화, 고령화 인구의 증가에 기인하는 것으로 보입니다. 이 기간 동안 예상되는 주요 동향으로는 인공지능과 머신러닝의 통합, 실시간 위험 계층화 도구의 개발, 전자의무기록 시스템과의 상호운용성 강화, 건강의 사회적 결정요인(SDOH) 데이터 수집, 위험 솔루션의 클라우드 기반 구축 등이 있습니다.
전자 의료 기록(EHR)의 사용 확대가 향후 몇 년 동안 임상 위험 그룹화 솔루션 시장의 성장을 견인할 것으로 예상됩니다. 전자의무기록은 환자의 종이 의무기록을 디지털화한 것으로, 권한이 있는 담당자가 실시간으로 환자 중심의 기록에 접근할 수 있습니다. EHR의 도입이 증가하는 이유는 보다 효율적인 데이터 관리가 요구되는 것이 주요 이유입니다. 의료 서비스 제공자는 환자 정보 저장 방식을 간소화하고, 접근성을 개선하며, 부서 간 협업을 강화하여 더 나은 임상적 판단과 건강 결과를 지원합니다. EHR의 사용은 환자의 정확한 위험 분류를 가능하게 하고, 효과적인 집단건강관리를 지원하는 종합적인 실시간 데이터를 제공함으로써 임상적 위험 그룹화 솔루션에 기여합니다. 예를 들어, 2022년 6월 영국 정부기관인 보건사회부는 2025년 3월까지 모든 NHS 트러스트가 전자 의료기록을 도입할 것으로 예상되며, 이는 2023년 12월까지 도입한 90%에서 증가할 것이라고 보고했습니다. 그 결과, 전자의무기록의 도입 확대가 임상 리스크 그룹화 솔루션 시장의 확대를 가속화하고 있습니다.
임상 리스크 그룹화 솔루션 시장의 주요 기업들은 인공지능(AI) 기반 코딩 플랫폼과 같은 첨단 솔루션에 투자하여 코딩 정확도를 높이고 리스크 평가 절차를 간소화하기 위해 노력하고 있습니다. 이 AI 탑재 플랫폼은 머신러닝, 자연어 처리 등의 기술을 활용해 임상 데이터를 평가하고 의료 코드를 정확하게 할당합니다. 이러한 플랫폼은 의료 코딩 워크플로우를 자동화하고, 수작업으로 인한 실수를 줄이고, 효율성을 향상시키며, 보다 효과적인 상환 및 치료 전략을 지원하는 정확한 위험 조정을 보장합니다. 머신러닝, 자연어 처리, 지능형 자동화를 결합하여 코딩의 정확도를 높이고, 임상 정보 분석을 간소화하며, 의료 보험 제도와 의료 서비스 제공자의 위험 관리 및 위험 조정 프로세스를 개선합니다. 이 플랫폼은 가상의 팀원으로서 복잡한 데이터를 분석하고, 맞춤형 규칙을 적용하여 계층적 병리 분류(HCC)를 정확하게 파악할 수 있도록 도와줍니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 임상 리스크 그룹화 솔루션 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 임상 리스크 그룹화 솔루션 시장 : 성장률 분석
세계의 임상 리스크 그룹화 솔루션 시장 실적 : 규모와 성장, 2019-2024
세계의 임상 리스크 그룹화 솔루션 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 임상 리스크 그룹화 솔루션 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 임상 리스크 그룹화 솔루션 시장 : 구성요소별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소프트웨어
서비스
세계의 임상 리스크 그룹화 솔루션 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
대시보드 분석
스코어카드와 데이터 시각화 툴
리스크 보고 솔루션
세계의 임상 리스크 그룹화 솔루션 시장 : 전개별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
프라이빗 클라우드
퍼블릭 클라우드
하이브리드 클라우드
세계의 임상 리스크 그룹화 솔루션 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
집단건강관리
만성질환 관리
임상 의사결정 지원
부정행위 검출과 방지
기타 용도
세계의 임상 리스크 그룹화 솔루션 시장 : 최종 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 진료소
외래 수술 센터
장기간병 센터
기타 최종사용자
세계의 임상 리스크 그룹화 솔루션 시장 : 하위 세분화 소프트웨어(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
대시보드 분석
스코어카드와 데이터 시각화 툴
리스크 보고 솔루션
세계의 임상 리스크 그룹화 솔루션 시장 : 하위 세분화 서비스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
구현 서비스
컨설팅 서비스
지원과 유지관리
제7장 지역별·국가별 분석
세계의 임상 리스크 그룹화 솔루션 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 임상 리스크 그룹화 솔루션 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
임상 리스크 그룹화 솔루션 시장 : 경쟁 구도
임상 리스크 그룹화 솔루션 시장 : 기업 개요
Optum Inc. Overview, Products and Services, Strategy and Financial Analysis
3M Corporation Overview, Products and Services, Strategy and Financial Analysis
Solventum Overview, Products and Services, Strategy and Financial Analysis
Conduent Inc. Overview, Products and Services, Strategy and Financial Analysis
Epic Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Cotiviti Inc.
Nuance Communications Inc.
Health Catalyst Inc.
Edifecs Inc.
Innovaccer Inc.
Cedar Gate Technologies
Reveleer
ZeOmega.
MedeAnalytics Inc.
Lightbeam Health Solutions
Apixio
HealthEC LLC
CareEvolution
HBI Solutions
4S Information Systems
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
임상 리스크 그룹화 솔루션 시장 2029 : 새로운 기회를 제공하는 국가
임상 리스크 그룹화 솔루션 시장 2029 : 새로운 기회를 제공하는 부문
임상 리스크 그룹화 솔루션 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
A clinical risk grouping (CRG) solution is a healthcare analytics system designed to categorize patients into clinically meaningful and mutually exclusive risk groups based on factors such as medical history, diagnoses, procedures, and other health-related data. This classification supports healthcare providers, payers, and policymakers in predicting healthcare utilization, managing population health, and optimizing resource allocation.
The core components of a clinical risk grouping solution include software and services. The software functions as a digital tool that classifies patients according to health risk to facilitate care management, lower costs, and support data-driven decision-making. The solution offers a range of products such as dashboard analytics, scorecards, data visualization tools, and risk reporting systems, and can be deployed via private, public, or hybrid cloud environments. Key applications encompass population health management, chronic disease management, clinical decision support, fraud detection and prevention, among other healthcare-related functions. It is used by various end-users including hospitals and clinics, ambulatory surgical centers, long-term care facilities, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The clinical risk grouping solution market research report is one of a series of new reports from The Business Research Company that provides clinical risk grouping solution market statistics, including the clinical risk grouping solution industry global market size, regional shares, competitors with the clinical risk grouping solution market share, detailed clinical risk grouping solution market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical risk grouping solution industry. These clinical risk grouping solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The clinical risk grouping solution market size has grown rapidly in recent years. It will grow from $0.61 billion in 2024 to $0.69 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth during the historic period can be attributed to regulatory initiatives promoting value-based care, the rise in healthcare data digitization, increasing healthcare costs, widespread adoption of electronic health records (EHR), and the expansion of risk adjustment programs.
The clinical risk grouping solution market size is expected to see rapid growth in the next few years. It will grow to $1.10 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to the shift toward personalized care management, the expansion of government healthcare programs, increasing demand for predictive analytics, a stronger focus on population health management, and a growing aging population. Key trends expected during this period include the integration of artificial intelligence and machine learning, the development of real-time risk stratification tools, enhanced interoperability with electronic health record systems, incorporation of social determinants of health (SDOH) data, and the cloud-based deployment of risk solutions.
The increasing use of electronic health records (EHRs) is anticipated to drive the growth of the clinical risk grouping solution market in the coming years. Electronic health records are digital representations of patients' paper charts that offer real-time, patient-focused records accessible to authorized personnel. The rising adoption of EHRs is largely due to the need for more efficient data management, as healthcare providers aim to streamline how patient information is stored, improve access, and enhance coordination among departments to support better clinical decisions and health outcomes. The use of EHRs contributes to clinical risk grouping solutions by supplying comprehensive, real-time data that enables accurate patient risk classification and supports effective population health management. For example, in June 2022, the Department of Health and Social Care, a government agency in the UK, reported that all NHS trusts are expected to implement electronic health records by March 2025, up from 90% that had adopted them by December 2023. Consequently, the growing adoption of electronic health records is accelerating the expansion of the clinical risk grouping solution market.
Key players in the clinical risk grouping solution market are investing in advanced solutions, such as artificial intelligence (AI)-powered coding platforms, to boost coding precision and simplify risk assessment procedures. These AI-powered platforms utilize technologies like machine learning and natural language processing to evaluate clinical data and assign medical codes accurately. They help automate the medical coding workflow, reduce manual errors, improve efficiency, and ensure precise risk adjustment, which supports more effective reimbursement and care strategies. For instance, in August 2022, Reveleer Inc., a healthcare technology firm based in the US, introduced Risk Adjustment 2.0-an AI-driven coding solution that combines machine learning, natural language processing, and intelligent automation to enhance coding accuracy, streamline the analysis of clinical information, and improve risk adjustment processes for health plans and providers managing risk. The platform functions as a virtual team member, analyzing complex data and applying custom rule sets to capture hierarchical condition categories (HCCs) accurately.
In October 2023, Optum Health Solutions (UK) Ltd., a healthcare service provider based in the UK, acquired EMIS Group plc for $1.5 billion (£1.2 billion). This acquisition aims to bolster Optum's presence in the UK healthcare sector by incorporating EMIS Group's advanced clinical software and data analytics expertise to enable more efficient and technology-driven healthcare delivery. EMIS Group plc is a UK-based company recognized for its work in clinical risk grouping solutions.
Major players in the clinical risk grouping solution market are Optum Inc., 3M Corporation, Solventum, Conduent Inc., Epic Systems Corporation, Cotiviti Inc., Nuance Communications Inc., Health Catalyst Inc., Edifecs Inc., Innovaccer Inc., Cedar Gate Technologies, Reveleer, ZeOmega, MedeAnalytics Inc., Lightbeam Health Solutions, Apixio, HealthEC LLC, CareEvolution, HBI Solutions, and 4S Information Systems.
North America was the largest region in the clinical risk grouping solution market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical risk grouping solution report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the clinical risk grouping solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The clinical risk grouping solution market consists of revenues earned by entities by providing services such as risk stratification, predictive analytics, patient classification, clinical decision support, population health management, claims and billing optimization, care coordination, and regulatory compliance and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical Risk Grouping Solution Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical risk grouping solution market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for clinical risk grouping solution ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical risk grouping solution market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Component: Software; Services
2) By Product: Dashboard Analytics; Scorecard And Data Visualization Tools; Risk Reporting Solutions
3) By Deployment: Private Cloud; Public Cloud; Hybrid Cloud
4) By Application: Population Health Management; Chronic Disease Management; Clinical Decision Support; Fraud Detection And Prevention; Other Applications
5) By End-use: Hospitals And Clinics; Ambulatory Surgical Centers; Long Term Care Centers; Other End-Users
Subsegments:
1) By Software: Dashboard Analytics; Scorecard And Data Visualization Tools; Risk Reporting Solutions
2) By Services: Implementation Services; Consulting Services; Support And Maintenance
Companies Mentioned: Optum Inc.; 3M Corporation; Solventum; Conduent Inc.; Epic Systems Corporation; Cotiviti Inc.; Nuance Communications Inc.; Health Catalyst Inc.; Edifecs Inc.; Innovaccer Inc.; Cedar Gate Technologies; Reveleer; ZeOmega; MedeAnalytics Inc.; Lightbeam Health Solutions; Apixio; HealthEC LLC; CareEvolution; HBI Solutions; 4S Information Systems.
3. Clinical Risk Grouping Solution Market Trends And Strategies
4. Clinical Risk Grouping Solution Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Clinical Risk Grouping Solution Growth Analysis And Strategic Analysis Framework
5.1. Global Clinical Risk Grouping Solution PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Clinical Risk Grouping Solution Market Growth Rate Analysis
5.4. Global Clinical Risk Grouping Solution Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Clinical Risk Grouping Solution Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Clinical Risk Grouping Solution Total Addressable Market (TAM)
6.1. Global Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Services
6.2. Global Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dashboard Analytics
Scorecard and Data Visualization Tools
Risk Reporting Solutions
6.3. Global Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Private Cloud
Public Cloud
Hybrid Cloud
6.4. Global Clinical Risk Grouping Solution Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Population Health Management
Chronic Disease Management
Clinical Decision Support
Fraud Detection And Prevention
Other Applications
6.5. Global Clinical Risk Grouping Solution Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Surgical Centers
Long Term Care Centers
Other End-Users
6.6. Global Clinical Risk Grouping Solution Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dashboard Analytics
Scorecard And Data Visualization Tools
Risk Reporting Solutions
6.7. Global Clinical Risk Grouping Solution Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Implementation Services
Consulting Services
Support And Maintenance
7. Clinical Risk Grouping Solution Market Regional And Country Analysis
7.1. Global Clinical Risk Grouping Solution Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Clinical Risk Grouping Solution Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Clinical Risk Grouping Solution Market
9.1. China Clinical Risk Grouping Solution Market Overview
9.2. China Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Clinical Risk Grouping Solution Market
10.1. India Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Clinical Risk Grouping Solution Market
11.1. Japan Clinical Risk Grouping Solution Market Overview
11.2. Japan Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Clinical Risk Grouping Solution Market
12.1. Australia Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Clinical Risk Grouping Solution Market
13.1. Indonesia Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Clinical Risk Grouping Solution Market
14.1. South Korea Clinical Risk Grouping Solution Market Overview
14.2. South Korea Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Clinical Risk Grouping Solution Market
15.1. Western Europe Clinical Risk Grouping Solution Market Overview
15.2. Western Europe Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Clinical Risk Grouping Solution Market
16.1. UK Clinical Risk Grouping Solution Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Clinical Risk Grouping Solution Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Clinical Risk Grouping Solution Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
